Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:00 pm Unchanged | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 448,101 4.600% | 0 (Unchanged) | View |
| 2024-02-14 2:23 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 1,078,459 9.990% | 122,464 (+12.81%) | View |
| 2023-11-24 1:43 pm Purchase | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,365,472 19.990% | 167,553 (+7.62%) | View |
| 2023-05-05 4:24 pm Purchase | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,197,919 19.990% | 2,197,919 (New Position) | View |
| 2023-02-14 12:06 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 955,995 9.990% | 23,943 (+2.57%) | View |
| 2023-02-14 11:02 am Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 448,101 5.200% | -48,655 (-9.79%) | View |
| 2023-02-09 11:07 am Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | VANGUARD GROUP INC | 181,843 2.110% | -248,235 (-57.72%) | View |
| 2022-11-18 3:01 pm Purchase | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BELLICUM PHARMACEUTICALS INC BLCM | 691,639 7.400% | 691,639 (New Position) | View |
| 2022-02-14 6:31 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 932,052 9.990% | 491,308 (+111.47%) | View |
| 2022-02-14 4:32 pm Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 496,756 5.900% | -3,244 (-0.65%) | View |
| 2022-02-09 3:24 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | VANGUARD GROUP INC | 430,078 5.120% | 430,078 (New Position) | View |
| 2021-02-16 5:10 pm Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 440,744 8.000% | -1,309,256 (-74.81%) | View |
| 2021-02-16 4:37 pm Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Boxer Capital LLC | 265,743 4.990% | -4,867,857 (-94.82%) | View |
| 2021-02-10 3:57 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | RENAISSANCE TECHNOLOGIES LLC | 26,631 0.530% | 26,631 (New Position) | View |
| 2021-01-08 9:57 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 500,000 9.900% | 500,000 (New Position) | View |
| 2020-02-14 3:42 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 1,750,000 3.400% | 1,750,000 (New Position) | View |
| 2020-02-12 4:07 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | RENAISSANCE TECHNOLOGIES LLC | 2,583,840 5.180% | 2,583,840 (New Position) | View |
| 2020-01-24 5:18 pm Sale | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,491,244 4.990% | -186,574 (-6.97%) | View |